Are patients with cystic fibrosis of six years and older able to use dry powder inhalers? A study of the effect of device resistance on flows and volumes
H. A. Tiddens, T. Standaert, P. Challoner, R. J. Spiers, K. C. Kesser, S. E. Overbeek, D. Humble, S. Shrewsbury, D. E. Geller (Rotterdam, The Netherlands; Seattle, Orlando, United States Of America)
Source: Annual Congress 2004 - Modern techniques bringing new insights into cystic fibrosis
Session: Modern techniques bringing new insights into cystic fibrosis
Session type: Thematic Poster Session
Number: 2397
Disease area: Airway diseases, Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. A. Tiddens, T. Standaert, P. Challoner, R. J. Spiers, K. C. Kesser, S. E. Overbeek, D. Humble, S. Shrewsbury, D. E. Geller (Rotterdam, The Netherlands; Seattle, Orlando, United States Of America). Are patients with cystic fibrosis of six years and older able to use dry powder inhalers? A study of the effect of device resistance on flows and volumes. Eur Respir J 2004; 24: Suppl. 48, 2397
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Comparison of total and fine drug particle mass generated from two dry powder inhalers (DPIs) by 4-year old children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study Source: Eur Respir J 2011; 38: 1071-1080 Year: 2011
Do asthma patients achieve effective dosing from dry powder inhalers (DPIs)? Source: Eur Respir J 2005; 26: Suppl. 49, 338s Year: 2005
Systemic availability (lung deposition) of drug from two different dry powder inhalers in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 429s Year: 2002
Inspiratory profiles and consistency of behaviour regarding dose delivery characteristics of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 13s Year: 2004
Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs) Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Computerized measurements of inhalation ability with a dry powder inhaler in patients with severe COPD Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020
Dose delivery characteristics of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 291s Year: 2004
The effect of a dry salt inhaler in adults with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006
Dry powder inhalers in asthma and COPD. Which factors determine the frequency of handling errors? Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology Year: 2007
Inspiratory profiles and resistance of two dry powder inhalers in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 291s Year: 2004
Applicability of dry powder inhalers in children with CF Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016
One-year height growth in children with asthma treated with inhaled budesonide delivered from a new dry powder inhaler. Source: Annual Congress 2008 - Clinical aspects of asthma in school-aged children Year: 2008
The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012
Peak inspiratory flow rates through placebo dry powder inhaler device in various asthma and COPD patients Source: Annual Congress 2012 - Asthma management Year: 2012
Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs) Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015
Breath activated inhaler usage and impact on rescue medication usage in patients with an asthma diagnosis: a prescribing claims study of 2823 patients using a CFC - pMDI and a breath-actuated device Source: Eur Respir J 2001; 18: Suppl. 33, 71s Year: 2001
A novel NEXT DPI® dry powder inhaler and its use in asthmatic and COPD population Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011
Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers Source: Annual Congress 2007 - Managing COPD in primary care Year: 2007
Analysis of peak inspiratory flow and use of dry powder inhalers in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019